Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.

The cost of complacency: Economist Intelligence Unit report underscores major gaps in world’s response to drug-resistant TB.

Advocates call on Indian Minister of Health to discontinue and phase out the drug donations of bedaquiline offered by Johnson & Johnson.

The guide details important efficacy, safety, and access information on rifapentine, a game-changing drug for treating TB infection in order to prevent active TB disease.

Sign the petition to urge governments to fully replenish the Global Fund!

International organizations unite on critical recommendations to combat drug-resistant infections and prevent staggering number of deaths each year.

MSF protests at J&J’s annual shareholders meeting to demand a say in how lifesaving TB drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable.

Two important tools for activists to use with donors and national TB programs in advocating for increased scale-up of the inexpensive, urine TB LAM test - an essential diagnostic test for TB in people living with HIV.

Statement by the Global TB Community Advisory Board to the High-level consultation on accelerating the development of the M72/AS01E tuberculosis vaccine candidate

TAG TB Project Co-Director Mike Frick discusses how public databases maintained by the NIH have been instrumental in supporting TAG's efforts to track global funding for TB research over time and hold governments and donors accountable to their TB research commitments.